SUMMARY: No trial evidence in pregnant women and more excuses not to asses reports of possible harms
After the great interest shown by the UK Parliament, our readers and the enablers at the MHRA, we continue reviewing the minutes of the 2 and 9 March 2021 meetings of the MHRA’s Commission On Human Medicines (CHM) COVID-19 Vaccines Benefit Risk Expert W…